All studies
CompletedInterventional

Does carbon dioxide reduce the chance of kidney problems in minimally invasive (endovascular) artery treatments?

Peripheral arterial disease causes narrow or blocked leg arteries, leading to poor circulation and pain. Doctors often treat this with a keyhole procedure using small balloons or stents to reopen the vessels. During this procedure, doctors inject a liquid iodine dye so the arteries show up clearly on X-ray screens. However, this dye can cause damage to the kidneys, particularly in people who already have chronic kidney disease. The KID trial compares the standard iodine dye with medical carbon dioxide gas. Carbon dioxide gas does not harm the kidneys and is safely absorbed by the body. Patients taking part will be randomly assigned to receive either the usual dye or carbon dioxide via an automated machine. If the gas images are not clear enough, doctors switch to the dye straight away. The trial aims to see if carbon dioxide prevents kidney damage and works well within the NHS.

At a glance

Status
Completed
Sponsor
University of Leicester
Enrolment target
174
Start
13 Feb 2025
Estimated completion
30 Jun 2026

What is this study about?

Many adults live with peripheral arterial disease (PAD), where the blood vessels supplying the legs become narrowed or blocked. This reduces blood flow, causing leg pain when walking, non-healing sores, and in severe cases, the risk of tissue loss. To restore healthy circulation, NHS specialists routinely perform keyhole procedures to gently stretch open the narrowed arteries.

To see where the blockages are during the procedure, specialists inject a contrast dye that highlights blood vessels on X-rays. While this dye works well, it can place extra stress on the kidneys. For patients who already live with chronic kidney disease (CKD), this extra strain can cause further, lasting damage to their kidney function.

The KID trial is looking at whether using carbon dioxide gas instead of liquid dye is a safer alternative. Carbon dioxide gas does not affect kidney health and dissolves naturally into the bloodstream within seconds. Doctors already use it in some cases, but this study tests a modern, automated injector machine across several NHS hospitals to gather firm evidence on how well it protects kidneys.

By taking part, patients help the NHS find out if this approach should become standard practice. If successful, using carbon dioxide could help people with reduced kidney function have vital circulation treatments with a lower risk of kidney complications.

Key takeaways

  • The KID trial tests whether carbon dioxide gas is safer for kidneys than standard dye during leg artery procedures.
  • It is designed for adults with both peripheral arterial disease and reduced kidney function.
  • Participants are randomly assigned to receive either standard iodine dye or carbon dioxide via an automated injector.
  • Doctors will switch to standard dye immediately if carbon dioxide images are unclear.
  • Health and kidney function are monitored for three months after the procedure.

Who may be eligible?

This trial is open to adults aged 18 and over who have peripheral arterial disease and are already booked for a keyhole procedure to widen or clear their leg arteries.

To be eligible, you also need to have known chronic kidney disease or blood test results showing reduced kidney function (an estimated glomerular filtration rate, or eGFR, below 60). Your hospital team can check these blood test results from your routine records.

You cannot take part if you are already on long-term kidney dialysis, or if you have a known allergy to standard iodine X-ray dye. You also need to be able to understand the trial information provided by the hospital team.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am 18 years of age or older.
  2. I have peripheral arterial disease (narrowed leg arteries).
  3. I am scheduled for a keyhole procedure to reopen my leg arteries.
  4. I have reduced kidney function or chronic kidney disease (eGFR under 60).
  5. I am not currently receiving long-term kidney dialysis.
  6. I do not have a known allergy to iodine-based X-ray dyes.
Answer every question to see your result.

What does participation involve?

Taking part does not change the main treatment you receive to open your leg arteries. You will undergo the planned keyhole procedure, usually done through a small tube inserted into a blood vessel in the groin. A computer system will randomly place you into one of two groups: one group receives the standard iodine dye, and the other receives carbon dioxide gas using an automated injector. If you receive carbon dioxide and the X-ray view is not clear enough at any point, your doctor will immediately add standard dye to keep your procedure safe and effective.

Before you go home, the team will check on your recovery. You will have routine follow-up checks over the next three months, during which the research team will monitor your general health and test your kidney function with routine blood tests. In total, your active involvement in the study lasts about three months from the day of your procedure.

Potential risks and benefits

There is no guarantee that taking part will directly improve your health, though you will receive close follow-up care and extra monitoring from the research team. If you receive carbon dioxide, it may help protect your kidneys from dye-related stress. Standard iodine dye carries a small risk of kidney strain and rare allergic reactions. Carbon dioxide gas may cause a brief tingling sensation or mild discomfort where it is injected, though the automated machine is designed to minimise this. The gas is safely cleared by your body before reaching the heart or brain. Joining the study is completely voluntary, and you can withdraw at any time without your regular NHS care being affected.

Locations (6)

  • Leicester Royal Infirmary
    Approximate
    Leicester, England
  • St Georges Hospital
    City only
    London, England
  • ST Thomas' Hospital
    Approximate
    London, England
  • University Hospitals of North Midlands NHS Trust
    City only
    Stoke-On-Trent, England
  • Manchester University NHS Foundation Trust
    City only
    Manchester, England
  • Hull Royal Infirmary
    Unverified
    Hull, England

Common questions

Is carbon dioxide gas dangerous to have in my bloodstream?

No. The tiny amount of carbon dioxide used is quickly and safely absorbed into your blood and breathed out naturally by your lungs before it can reach your brain or heart.

Can I choose whether I get carbon dioxide or the standard dye?

No. A computer randomly decides which group you join. This ensures the study results are fair, accurate, and unbiased.

What happens if the carbon dioxide pictures are not clear enough?

Your doctor's main priority is always your safety. If the gas does not show the artery clearly, they will immediately switch to standard iodine dye to finish opening your artery.

Will taking part delay my artery procedure?

Using the carbon dioxide machine might add just a few minutes to the setup time, but your procedure will take place on your scheduled date as planned.

Will I have to pay for anything during the trial?

No. The trial is funded by the National Institute for Health and Care Research (NIHR) and all study-related care is provided through the NHS at no cost to you.

How to find out more

Dania Tapia-Aguirre

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.